Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Weinmann Geräte für Medizin GmbH + Co. KG | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
15 COPD patients will be surveyed in this prospective randomized crossover pilot study concerning non invasive ventilation. Patients will be treated over 2 nights in randomized order with Ventimotion2 (Weinmann) with and without Airtrap Control under Polysomnography (PSG) surveillance including transcutaneous pCO2 measurement. The sleep quality is judged by evaluating the PSG and pCO2 values over night.
Target parameters are respiratory rate, sleep quality and influence of Airtrap Control on pCO2 values over night.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| bilevel ventilation BIPAP ST | Active Comparator | one night, BIPAP ST ventilation with individually optimised pressure parameters and supplemental oxygen if necessary. |
|
| BIPAP ST plus Airtrap | Experimental | one night, BIPAP ST ventilation with "Airtrap control", same pressure parameters and oxygen. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BIPAP ST | Device | non invasive ventilation, individually titrated for each patient, if necessary combined with oxygen, to improve hypercapnic respiratory failure. |
|
| Measure | Description | Time Frame |
|---|---|---|
| breathing frequency | breathing frequency measured with the flow signal of a polysomnography during non invasive ventilation over night | 2 nights |
| Measure | Description | Time Frame |
|---|---|---|
| mean pCO2 level | mean pCO2 level over night measured with a transcutanous pCO2 monitor (TOSCA) | 2 nights |
| Measure | Description | Time Frame |
|---|---|---|
| Sleep efficiency | Sleep efficiency is defined by the relation of "time in bed" to "total sleep time" in the overnight polysomnography protocol | 2 nights |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Georg Nilius, MD | Helios Klinik Hagen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Helios Klinik Hagen | Hagen | North Rhine-Westphalia | 58091 | Germany |
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| D012131 | Respiratory Insufficiency |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Airtrap | Device | Addional to the individally titrated BiPAP ventilation parameters the function "AirTrap Control" is added. AirTrap Control helps to prevent dynamic hyperinflation and makes it possible for VENTImotion 2 to automatically regulate to the best frequency and expiration time. |
|
|
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012120 | Respiration Disorders |